供应商免费入驻

仪器信息网试剂标物生化试剂生物分子 Motesanib

仪信通第 2 年

爱必信(上海)生物科技有限公司

认证：工商信息已核实

厂商展位

找不到产品？留下需求帮您找

一键询价

Motesanib

价格：￥ 1850

品牌：爱必信

供货周期：一周

货号：abs817471

规格：≥98%

CAS：453562-69-1

一键咨询

获取电话

详细信息

详细信息

公告提醒：爱必信所有产品和服务仅用于科学研究，不用于临床应用及其他用途提供产品和服务（也不为任何个人提供产品和服务）!

抑制剂描述：

产品名称：Motesanib

产品别名：见爱必信官网

英文别名：Motesanib

靶点：VEGFR

CAS：453562-69-1

纯度：≥98%

外观：见爱必信官网

保存方法：store at -20℃ for one year（Powder）； in DMSO or others solvent store at 2-4℃ for two weeks, at -20℃ for six months.

描述：Motesanib is an orally bioavailable receptor tyrosine kinase inhibitor with potential antineoplastic activity. AMG 706 selectively targets and inhibits vascular endothelial growth factor (VEGFR), platelet-derived growth factor (PDGFR), Kit, and Ret receptors, thereby inhibiting angiogenesis and cellular proliferation.

溶解性：DMSO : ≥ 30 mg/mL (80.33 mM)

体外研究：

Motesanib has broad activity against the human VEGFR family, and displays > 1000 selectivity against EGFR, Src, and p38 kinase. Motesanib significantly inhibits VEGF-induced cellular proliferation of HUVECs with an IC50 of 10 nM, while displaying little effect at bFGF-induced proliferation with an IC50 of >3,000 nM. Motesanib also potently inhibits PDGF-induced proliferation and SCF-induced c-kit phosphorylation with IC50 of 207 nM and 37 nM, respectively, but not effective against the EGF-induced EGFR phosphorylation and cell viability of A431 cells. Althouth displaying little antiproliferative activity on cell growth of HUVECs alone, Motesanib treatment significantly sensitizes the cells to fractionated radiation.

体内研究：Motesanib (100 mg/kg) significantly inhibits VEGF-induced vascular permeability in a time-dependent manner. Oral administration of Motesanib twice daily or once daily potently inhibits, in a dose-dependent manner, VEGF-induced angiogenesis using the rat corneal model with ED50 of 2.1 mg/kg and 4.9 mg/kg, respectively. Motesanib induces a dose-dependent tumor regression of established A431 xenografts by selectively targeting neovascularization in tumor cells. Motesanib in combination with radiation displays significant anti-tumor activity in head and neck squamous cell carcinoma (HNSCC) xenograft models. Motesanib treatment also induces significant dose-dependent reductions in tumor growth and blood vessel density of MCF-7, MDA-MB-231, or Cal-51 xenografts, which can be markedly enhanced when combined with docetaxel or tamoxifen.

产品信息订购：

产品货号	产品名称	规格	价格	大包装及货期
abs817471	Motesanib	10mg	1850.00	立即咨询
abs817471	Motesanib	50mg	5550.00	立即咨询

产品更多信息请进入爱必信网站咨询

生化试剂 Motesanib由爱必信(上海)生物科技有限公司为您提供，如想了解更多关于生物分子 Motesanib的报价、规格、厂家等信息，欢迎来电或留言咨询。除供应Motesanib外，爱必信(上海)生物科技有限公司还可为您提供：

推荐专场